Go to the list of all blogs
Anna G's Avatar
published in Blogs
Mar 14, 2023
How Artificial Intelligence Can Boost your Trading Results

How Artificial Intelligence Can Boost your Trading Results

Using the right tools can make any task easier. In the past, stock traders had to spend countless hours poring over charts, graphs, and financial reports, and creating spreadsheets to predict market movements. This process was time-consuming and put a lot of pressure on traders to make each trade count.

Today, technology has made things much easier. Reporting and analytics are available at the touch of a button, and artificial intelligence can analyze data to provide insights on when and what to trade. This may sound like something out of science fiction, but AI is already being used by traders worldwide to conduct a higher volume of trades and make more money.

Interestingly, the idea of using mathematics to predict behavior patterns of large groups was first introduced by Isaac Asimov in his 1951 science fiction classic, "Foundation." Asimov called this idea "psychohistory," and although he applied it to humans, his description closely resembles the algorithms used by modern AI programs.

The Mathematics of Trading in the Modern Day

The stock market is often perceived by outsiders as a game of chance, but traders understand the truth: economic behavior and financial trends can be predicted. While unforeseen events like pandemics can cause chaos, they are rare occurrences, and traders can still thrive in such situations. However, predicting market trends can be overwhelming for the human mind, leading to a high burnout rate for day traders. Emotion also plays a significant role in decision-making, making it challenging to leave it out.

For scalpers and momentum traders who make numerous decisions during an eight-hour trading day, it is nearly impossible to do so effectively without modern technology. That is why only about ten percent of traders succeed. However, the introduction of artificial intelligence has revolutionized the game, making science fiction a reality.

One such product is Tickeron Screener, which combines technical and fundamental analysis to predict market movements. This AI technology uses mathematical trends, historical financial reports, and behavioral analysis to determine which stocks have been overbought or oversold, providing valuable insights to traders. By having this information at their fingertips, traders can make better trade decisions without spending hours on research.

The AI algorithm used in Tickeron Screener "thinks" thousands of times faster than a human, allowing traders to benefit from speed, which is a trader's best friend. With every data point being a variable that's plugged into the algorithm, traders can significantly improve their odds of success. Say goodbye to tiresome research and hello to better trade decisions with Tickeron Screener.

Screener offers several advantages, one of which is the ability to identify areas where you can add value to your portfolio. By adding additional sectors, you can improve your diversification score and track market trends in areas you may not have explored before. There are opportunities beyond traditional investments like forex, tech, and energy stocks that Screener can help you uncover, making you a more well-rounded trader.

Achieve Better Returns with Tickeron's Active Portfolios

While the science fiction tale "Rise of the Machines" is a fascinating read, it's important to remember that we never want machines to have complete control. At Tickeron, we understand the value of human portfolio construction, which is why we offer "Active Portfolios," a product that combines the best of both worlds - AI trading and human expertise. With our Active Portfolios, you can achieve better returns and beat the benchmark, without relinquishing complete control to machines.

Active Portfolios (AP) is revolutionizing the investment game. With its powerful screener, it saves you valuable time by taking care of all the setup once you have established your investment strategy. All you need to do is choose a portfolio that aligns with your trading goals and preferences, whether it's stocks and ETFs, forex and crypto, or a combination of both. You can easily sort the portfolios by annualized returns, number of positions, or number of monthly trades.

The portfolios offered by AP are curated and managed by human experts, while AI technology makes recommendations on when and what to trade. This powerful combination is what we call tech-enabled software, much like the autopilot on a plane. You have the flexibility to let the computer take over when you want to sit back, but you can always regain control when necessary.

Tickeron’s Approach to Fintech: Artificial Intelligence for Retail Investors

Hedge funds and large institutional investors have been using Artificial Intelligence to analyze large data sets for investment opportunities, and they have also unleashed A.I. on charts to discover patterns and trends. Not only can the A.I. scan thousands of individual securities and cryptocurrencies for patterns and trends, and it generate trade ideas based on what it finds. Hedge funds have had a leg-up on the retail investor for some time now.

Not anymore. Tickeron has launched a new investment platform, and it is designed to give retail investors access to sophisticated AI for a multitude of functions:

Finding stock patterns in the market
Finding trends in the stock market
Testing portfolios to see if they are well-diversified
Back-testing statistics to see how different stock patterns generated trading results
Making Predictions for price movements in the future, with “A.I. Rank” and level of confidence in the trade.
And much more. No longer is AI just confined to the biggest hedge funds in the world. It can now be accessed by everyday investors. Learn how on Tickeron.com.

Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.